NIH-Funded AI-READI Project Creates Ethical AI-Ready Dataset for Type 2 Diabetes Research
Summary
The AI-READI project, funded by the NIH Bridge2AI Program, aims to create a flagship, ethically-sourced dataset optimized for AI/ML analysis in type 2 diabetes research. The project focuses on generating high-quality data, best practices, and tools to support future AI-driven discoveries in diabetes, with an emphasis on ethical data sourcing and accessibility for the research community.
Source
Twitter / XNIH-Funded AI-READI Project Creates Ethical AI-Ready Dataset for Type 2 Diabetes Researchaireadi.orgKey quotes
· 4 pulledGenerating a flagship AI-ready and ethically-sourced dataset to support future AI-driven discoveries in diabetes
AI-READI is one of the data generation projects of the National Institutes of Health (NIH) funded Bridge2AI Program
The AI-READI project seeks to create and share a flagship dataset of type 2 diabetes
The data will be optimized for future artificial intelligence/machine learning (AI/ML) analysis that could provide critical insights
You might also wanna read
Google DeepMind partners with Wellcome Sanger Institute to build AI-ready genomic datasets
Google DeepMind and Google.org have partnered with the Wellcome Sanger Institute to build high-quality genomic datasets that will serve as t
cen.acs.org·26d ago
NIHR awards £8.1 million to AI projects including Oxford studies to reduce NHS waiting times
The NIHR has awarded £8.1 million through its Invention for Innovation (i4i) programme to six AI and digital innovation projects aimed at re
digitalhealth.net·13d ago
OpenAI launches GPT-Rosalind AI model for biology and drug discovery research
OpenAI introduces GPT-Rosalind, a frontier reasoning model designed to support research in biology, drug discovery, and translational medici
openai.com·1mo ago
Data Provenance and Metadata Quality: Critical Vulnerabilities in Genomic Research and AI-Driven Biology
This article examines the critical problem of poor data provenance, weak metadata standards, and lack of material authentication in publicly
zenodo.org·1mo ago
AI Drug Discovery Stalled by Lack of Trustworthy Biological Data
The article discusses the gap between AI's potential in drug discovery and actual results, attributing the productivity gap to the quality a
the-scientist.com·15d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.